UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Oct

    17

    Steadfast Towards Our Ambition to Create a UCB Rare Disease Portfolio

    Read More Share:linkedin| twitter| email| facebook

    Sep

    11

    UCB PharmD Second-Year Fellows Share Reflections and Advice

    Read More Share:linkedin| twitter| email| facebook

    Aug

    03

    Employee Spotlight: David Hornbaker’s Heart for Helping Patients

    Read More Share:linkedin| twitter| email| facebook

    Aug

    01

    Evolving Expectations for Dermatological Conditions

    Read More Share:linkedin| twitter| email| facebook

    Jun

    27

    Fulfilling Our Ambition to Deliver an FDA-Approved Treatment for People Living with Generalized Myasthenia Gravis

    Read More Share:linkedin| twitter| email| facebook

    Jun

    14

    How UCB Is Supporting the Mental Health of Patients and Caregivers

    Read More Share:linkedin| twitter| email| facebook

    Jun

    14

    Recognizing Ethical Leadership at UCB

    Read More Share:linkedin| twitter| email| facebook

    Jun

    02

    Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome

    Read More Share:linkedin| twitter| email| facebook

    Jun

    01

    Myasthenia Gravis Awareness Month is the Time to Understand More About the Lived Experiences of the Community

    Read More Share:linkedin| twitter| email| facebook

    Apr

    27

    Voices on Value: Breaking Down the Value Chain: The Policies Impacting Patients

    Read More Share:linkedin| twitter| email| facebook

    © 2009 - 2025 UCB, Inc. Atlanta. All rights reserved. 
    Last updated: August 2025